4.27 USD
↘ 0.06 (1.39%)LIVE (AS OF 10:17 AM EDT)
Galmed Pharmaceuticals Ltd.
GLMDNASDAQ • USD
Market: OPEN
Galmed Pharmaceuticals Ltd. (GLMD) is currently trading at $4.27. The stock presents a bearish profile across the board: technical indicators signal "Strong Sell" and our fundamental models agree with a "Sell" rating. Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment.
Technical & fundamental data as of Aug 26, 2026.
Open?$4.29
High?$4.38
Low?$4.23
Prev. Close?$4.33
Volume?1.6K
Avg. Volume?N/A
VWAP?$4.28
Bid / Ask
Bid?$3.44 × 100
Ask?$5.02 × 100
Spread?$1.58
Midpoint?$4.23
Valuation & Ratios
Market Cap?4.5M
Shares Out?1.0M
Float?7.9M
Float %?95.8%
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
News
Profile
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. The company focuses on the development of Aramchol for combination therapy for GI oncological indications. The company is actively pursuing opportunities in the biotech and medtech spaces to expand and diversify its product pipeline targeting GI, cardiometabolic indications and other product candidates.
Themes
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?50
Short Sent.?80
Piotroski F-Score?0/9Weak
Altman Z-Score?-33.46Distress
Confidence?33%Very Low
Short InterestLow
Short % of Float?0.47%Low
Short Interest?37.3K
Days to Cover?1.0
Free Float7.9M
Avg Daily Volume40.1K
Settlement Date2026-08-14